top of page
GT Logo White.png

2026
Daiichi Sankyo 

Golden Ticket

biolabslogo.png
daiichi-sankyo.color_logo.png

Daiichi Sankyo is sponsoring a competition to award up to 2 Golden Tickets at BioLabs San Diego. Each Golden Ticket provides one year of fully paid individual bench space and membership at a fully equipped laboratory designed to accelerate early-stage startup working on research and development of novel technology platform and/or modality that could provide several drug candidates regardless of disease area.​

​

Additional eligibility requirement are listed below and also on the Terms and conditions document.

Application Process

The official application process can be found below. Please read and verify your availability before submitting your application. 

calendar.png

Application

Complete the online application form and upload a non-confidential pitch deck for this competition.

​

laptop.png

Terms & Conditions

Read more about the judging criteria and judges. Scientific experts will review your application and select the most promising ones.

lightbulb.png
Benefits

Golden Ticket Benefits

_40A4948.jpg

1-year membership and

a lab bench

to de-risk your technology and scale your business 

pa.jpeg

A buzzing community

of entrepreneurs

connecting startups to local orgs and investors

_40A4848.jpg

A no strings

attached model

to maintain complete ownership of your IP

shutterstock_1654598800.jpg

Unparalleled suite of laboratory equipment,

to execute your research and development

pa.jpeg

A diverse scientific community

of entrepreneurs and industry leaders

christina-wocintechchat-com-DcHbAegafZg-unsplash.jpg

Mentoring and support from Daiichi Sankyo​

drug discovery and development experts 

MicrosoftTeams-image4072ff6cdfbe3f3b659bf511b8cddfd93d42c64b15b1c4048053eed0e94325b7.png

Gateway to a

potential collaboration

with Daiichi Sankyo​​, a leading pharma partner 

Eligibility Snapshot
BioLabs Innovation Center at UVM is looking for biotech companies working on research and development of non-viral delivery technologies de-targeting the liver, ideally used for the treatment of rare diseases with the following eligibility requirements:

  • A novel technology platform and/or modality that provides several drug candidates regardless of disease area (medical device, diagnostics and manufacturing are out of scope)​

  • An Innovative technology compared to existing technologies and/or modalities​

  • expanding the scope of the technology and/or modality for disease treatment​

Eligibility
App Process

The Application Process

01

Submit the online application by January 08, 2027

02

A subset of applications will be identified as finalist by the contest judges by
January 29, 2027

03

Finalist teams will present their company & scientific concept at an in-person in BioLabs San Diego, event on
February 10, 2027

04

One award will be granted
Good luck!

Contact Us

If you have any questions regarding this competition contact goldenticket.risd@daiichisankyo.com

If you have any questions about BioLabs contact​

goldenticket@biolabs.io

shutterstock_408838849_edited.jpg
bottom of page